On Categorizing Gestational, Birth, and Neonatal Complications Following Late Pregnancy Exposure to Antidepressants: The Prenatal Antidepressant Exposure Syndrome

被引:48
|
作者
Gentile, Salvatore [1 ]
机构
[1] ASL Salerno, Mental Hlth Ctr 63, I-84013 Salerno, Italy
关键词
SEROTONIN-REUPTAKE INHIBITORS; IN-UTERO EXPOSURE; PERSISTENT PULMONARY-HYPERTENSION; PAROXETINE WITHDRAWAL SYNDROME; MATERNAL CLOMIPRAMINE THERAPY; CONGENITAL-MALFORMATIONS; DISCONTINUATION SYNDROME; PRETERM BIRTH; PSYCHIATRIC-DISORDERS; ANTENATAL DEPRESSION;
D O I
10.1017/S1092852900027449
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Late in utero exposure to antidepressants has been suspected of adversely impacting pregnancy outcome and compromising neonatal adaptation. Hence, the necessity exists to analyze published information on antidepressant use during late pregnancy to individuate potential recurrent patterns of iatrogenic complications. Methods: Computerized searches on MEDLINE, PsycINFO, ENBASE, and Cochrane Library through February 10, 2010 were performed for selecting literature information and investigating the safety of antidepressants when used during late pregnancy. Results: Antidepressant treatment during late pregnancy may increase the rates of poor pregnancy outcome and neonatal withdrawal/toxic reactions. Conclusions: Because both gestational complications and neonatal adverse events acknowledge the same etiology, the author suggests including such iatrogenic events under the definition of prenatal antidepressant exposure syndrome, in order to increase clinicians' awareness about the spectrum of risks which may concern the mother-infant pair when antidepressant treatment is deemed indispensable during late pregnancy. CNS Spectr. 2010; 15(3):167-185
引用
收藏
页码:167 / 185
页数:19
相关论文
共 50 条
  • [1] Neonatal and pregnancy complications following maternal depression or antidepressant exposure: A population-based, retrospective birth cohort study
    Su, Jian-An
    Chang, Chih-Cheng
    Yang, Yao-Hsu
    Lee, Chuan-pin
    Chen, Ko-Jung
    Lin, Chung-Ying
    ASIAN JOURNAL OF PSYCHIATRY, 2023, 84
  • [2] Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir
    Vannappagari, Vani
    Thorne, Claire
    Albano, Jessica D.
    Bowen, Mandy
    Cook, Taylor
    Garges, Harmony
    Ragone, Leigh
    Scheuerle, Angela E.
    Tilson, Hugh
    Xue, Yuming
    Vielot, Nadja
    Aebi-Popp, Karoline
    Burger, David
    Colbers, Angela
    Floridia, Marco
    Giaquinto, Carlo
    Goetghebuer, Tessa
    Peters, Helen
    Pozniak, Anton
    Soriano-Arandes, Antoni
    Sovric, Milena
    Sconza, Rebecca
    Francis, Kate
    Horn, Anna
    Tookey, Pat
    Delforge, Marc
    Van Der Kelen, Evelyne
    Konopnicki, Deborah
    Weizsacker, Katharina
    Hidalgo Tenorio, Carmen
    van Crevel, Reinout
    Masuelli, Giulia
    Spinillo, Arsenio
    Meloni, Alessandra
    Polizzi, Cosimo
    Noguera-Julian, Antoni
    Fortuny, Claudia
    Soler-Palacin, Pere
    Mendoza, Natalia
    Mur, Antonio
    Garcia, Lourdes
    Scherrer, Alexandra
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 (04) : 371 - 378
  • [3] Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data
    Malm, Heli
    Sourander, Andre
    Gissler, Mika
    Gyllenberg, David
    Hinkka-Yli-Salomaeki, Susanna
    McKeague, Ian W.
    Artama, Miia
    Brown, Alan S.
    AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (12) : 1224 - 1232
  • [4] Prenatal exposure to polycyclic aromatic hydrocarbons and gestational age at birth
    Freije, Sophia L.
    Enquobahrie, Daniel A.
    Day, Drew B.
    Loftus, Christine
    Szpiro, Adam A.
    Karr, Catherine J.
    Trasande, Leonardo
    Kahn, Linda G.
    Barrett, Emily
    Kannan, Kurunthachalam
    Bush, Nicole R.
    LeWinn, Kaja Z.
    Swan, Shanna
    Mason, W. Alex
    Robinson, Morgan
    Sathyanarayana, Sheela
    ENVIRONMENT INTERNATIONAL, 2022, 164
  • [5] Prenatal phthalate exposure and infant size at birth and gestational duration
    Shoaff, Jessica R.
    Romano, Megan E.
    Yolton, Kimberly
    Lanphear, Bruce P.
    Calafat, Antonia M.
    Braun, Joseph M.
    ENVIRONMENTAL RESEARCH, 2016, 150 : 52 - 58
  • [6] Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication
    Lewis, Andrew J.
    Galbally, Megan
    Opie, Gillian
    Buist, Anne
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 (05) : 482 - 487
  • [7] Prenatal antidepressant exposure and sex differences in neonatal corpus callosum microstructure
    Campbell, Kayleigh S. J.
    Williams, Lynne J.
    Bjornson, Bruce H.
    Weik, Ella
    Brain, Ursula
    Grunau, Ruth E.
    Miller, Steven P.
    Oberlander, Tim F.
    DEVELOPMENTAL PSYCHOBIOLOGY, 2021, 63 (06)
  • [8] The Effect of Prenatal Antidepressant Exposure on Neonatal Adaptation: A Systematic Review and Meta-Analysis
    Grigoriadis, Sophie
    VonderPorten, Emily H.
    Mamisashvili, Lana
    Eady, Allison
    Tomlinson, George
    Dennis, Cindy-Lee
    Koren, Gideon
    Steiner, Meir
    Mousmanis, Patricia
    Cheung, Amy
    Ross, Lori E.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (04) : E309 - +
  • [9] The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies
    Tak, Casey R.
    Job, Kathleen M.
    Schoen-Gentry, Katie
    Campbell, Sarah C.
    Carroll, Patrick
    Costantine, Maged
    Brixner, Diana
    Birnbaum, Angela K.
    Sherwin, Catherine M. T.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (09) : 1055 - 1069
  • [10] Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
    Shea, Alison K.
    Wang, Dong Yao
    Snelgrove, John W.
    Dalfen, Ariel
    Hewko, Sheryl
    Murphy, Kellie E.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2021, 43 (06) : 726 - 732